Merit Medical Systems | MMSI - Los Gastos De Explotación

Precio De Mercado
61.36
Cambio Diario
-1.20 -1.92%
Mensual
-12.47%
Anual
-37.91%
Q2 Expectativa
60.13




Los Gastos De Explotación Cambio Fecha
3M USD 3.26B 1.66B 2026-03
Abbott USD 9.31B 104M 2026-03
AngioDynamics USD 81.95M 1.68M 2025-09
Anika Therapeutics USD 133.9M 103.93M 2026-03
AtriCure USD 140.72M 2.71M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 595.85M 49.26M 2026-03
Haemonetics USD 134.99M 1.26M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
J&J USD 17.44B 1.53B 2026-03
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 337.72M 2.02M 2026-03
Olympus JPY 268.42B 35.37B 2026-03
Pfizer USD 90.1B 77.19B 2026-03
STAAR Surgical USD 76.12M 7.38M 2026-03
Stryker USD 4.92B 284M 2026-03
Surmodics USD 29.51M 274.86M 2025-06
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
Terumo JPY 252.74B 22.88B 2025-12
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03